HUMORAL IMMUNITY IN MYASTHENIA GRAVIS: CLINICAL CORRELATIONS OF ANTI‐RECEPTOR ANTIBODY AVIDITY AND TITER*
1981; Wiley; Volume: 377; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1981.tb33741.x
ISSN1749-6632
Autores Tópico(s)Antifungal resistance and susceptibility
ResumoAnnals of the New York Academy of SciencesVolume 377, Issue 1 p. 316-331 HUMORAL IMMUNITY IN MYASTHENIA GRAVIS: CLINICAL CORRELATIONS OF ANTI-RECEPTOR ANTIBODY AVIDITY AND TITER* Richard S. A. Tindall, Richard S. A. Tindall Department of Neurology southwestern Medical School Dallas, Texas 75235Search for more papers by this author Richard S. A. Tindall, Richard S. A. Tindall Department of Neurology southwestern Medical School Dallas, Texas 75235Search for more papers by this author First published: December 1981 https://doi.org/10.1111/j.1749-6632.1981.tb33741.xCitations: 43 * Supported by grants from Muscular Dystrophy Association and the General Clinical Research Center (USPHS No. 1-MO1-RR00633). AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Almon, K. R., C. G. Andres & S. H. Appel. 1974. Serum globulin in myasthenia inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science 186: 55–57. 2 Bender, A. N., S. P. Ringel et al. 1975. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet 1: 607–609. 3 Aharanov, A., O. Abramsky & R. Tarrab-Hazdai et al. 1975. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet 2: 340–342. 4 Mitlag, P. & A. Kornfield et al. 1976. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N. Engl. J. Med. 294: 691–694. 5 Lindstrom, J. 1977. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin. Immunol. Immunopathol. 7: 36–43. 6 Lindstrom, J. M., M. E. Seybold & A. Lennon. 1976. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value. Neurology 26: 1054–1059. 7 Monnier, V. M. & B. W. Fulpius. 1977. A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin. Exp. Immunol. 29: 16–22. 8 Lefvert, A. K., K. Bergstrom & G. Matell, et al. 1978. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiatry 41: 394–403. 9 Fambrough, D. M., D. B. Drachman & S. Santyamurti. 1973. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293–5. 10 Engel, A. G., J. M. Lindstrom & E. H. Lambert et al. 1977. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology 27: 307–315. 11 Lindstrom, J. & E. H. Lambert. 1978. Content of acetylcholine receptor in myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton-Lambert syndrome. Neurology 28: 130–138. 12 Shibuya, N., M. Katzutake & Y. Nakazawa. 1978. Serum factor blocks neuromuscular transmission in myasthenia gravis. Electrophysiologic study with intracellular micro-electrodes. Neurology 28: 804–811. 13 Rash, J. E., E. X. Albuquerque & C. S. Hudson et al. 1976. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex. Proc. Natl. Acad. Sci. USA 73: 4584–4588. 14 Heinemann, S., J. Merlie & J. Lindstrom. 1978. Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature 274: 65–68. 15 Drachman, D. B., C. W. Angus & P. N. Adams et al. 1978. Effect of myasthenic immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proc. Natl. Acad. Sci. USA 75: 3422–3426. 16 Appel, S. H., R. Anwyl & M. W. Mcadams et al. 1977. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc. Natl. Acad. Sci. USA 74: 2130–2134. 17 Drachman, D. B., R. N. Adams & E. F. Stanley et al. 1980. Mechanisms of acetylcholine receptor loss in myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 43: 601–610. 18 Engel, A. G. 1980. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes. J. Neurol Neurosurg. Psychiatry. 43: 577–589. 19 Toyka, K. V., D. B. Drachman & D. E. Griffin et al. 1977. Myasthenia gravis, study of humoral immune mechanism by passive transfer to mice. N. Engl. J. Med. 296: 125–131. 20 Pinching, A. J., D. K. Peters & J. Newsom-Davis. 1976. Remission of myasthenia gravis following plasma exchange. Lancet 2: 1373–1376. 21 Vincent, A., A. J. Pinching & J. Newsom-Davis. 1977. Circulating antiacetylcholine receptor antibody in myasthenia gravis treated with plasma exchange. Neurology 27: 364. 22 Dau, P. C., J. M. Lindstrom & J. K. Cassel et al. 1977. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N. Engl. J. Med. 297: 1134–1140. 23 Newsom-Davis, J., A. J. Pinching & A. Vincent et al. 1978. Function of circulating antibody to acetylcholine receptor in myasthenia gravis investigated by plasma exchange. Neurology 28: 266–272. 24 Vincent, A. & J. Newsom-Davis. 1980. Antiacetylcholine receptor antibodies. J. Neurol. Neurosurg. Psychiatry 43: 590–600. 25 Lindstrom, J., M. Campbell & B. Nate. 1978. Specificities of antibodies to acetylcholine receptors. Muscle and Nerve 1: 140–145. 26 Weinberg, C. B. & Z. W. Hall. 1979. Antibodies from patients with myasthenia gravis recognize determinants unique to extra-junctional acetyl-choline receptors. Proc. Natl. Acad. Sci. USA 76: 504–508. 27 Vincent, A. & J. Newsom-Davis. 1978. Studies on alpha-bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. In Neurotoxins: Tools in Neurobiology. Adv. Cytopharmacol. 3: 269–278. 28 Mcadams, M. W. & A. D. Roses. 1980. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis. Ann. Neurol. 8: 61–66. 29 Perlo, V. P., D. C. Poskanzer & R. S. Schwab et al. 1966. Myasthenia gravis: evaluation of treatment in 1355 patients. Neurology 16: 431–439. 30 Lindstrom, J. & J. Patrick. 1974. Purification of the acetylcholine receptor by affinity chromatography. In Synaptic Transmission and Neuronal Interaction. E. Bennett, Ed. 191–216. Raven Press, New York , NY . 31 Mahler, H. R. & E. H. Cordes. 1975. Biological Chemistry.: 219–237. Harper and Row. New York , NY . 32 Tindall, R. S. A. 1980. Humoral immunity in myasthenia gravis: effect of thymectomy and steroids. Neurology 30: 554–557. 33 Dwyer, D. A., R. J. Bradley, S. J. Oh et al. 1979. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis, Clin. Exp. Immunol. 37: 448–451. 34 Lindstrom, J. M. 1980. Experimental autoimmune myasthenia gravis. J. Neurol. Neurosurg. Psychiatry. 43: 568–576. 35 Tzartos, S. & J. J. Lindstrom. 1980. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. USA. 77: 755–759. Citing Literature Volume377, Issue1Myasthenia Gravis: Pathophysiology and ManagementDecember 1981Pages 316-331 ReferencesRelatedInformation
Referência(s)